Advertisement
Home Tags Cancer: Bladder

Tag: Cancer: Bladder

Among postmenopausal women

Quitting Smoking Lowers Risk for Bladder Cancer Postmenopause

Significant drop seen in first 10 years of cessation, continues to decrease as cessation time increases

American Urological Association, May 3-6

The American Urological Association 2019 Annual Meeting The annual meeting of the American Urological Association was held from May 3 to 6 in...
The first personalized treatment for patients with metastatic bladder cancer and susceptible fibroblast growth factor receptor genetic alterations was granted accelerated approval by the U.S. Food and Drug Administration

FDA Approves Personalized Tx for Metastatic Bladder Cancer

Balversa indicated for treatment of bladder cancer with FGFR3 or FGFR2 genetic alteration
An earlier age at menopause is associated with a higher risk for bladder cancer

Younger Age at Menopause Tied to Higher Risk for Bladder Cancer

Women with menopause onset by age 45 at higher risk than those with onset at age 50 or older
Cigarette smoking is linked to a poor response to cisplatin-based neoadjuvant chemotherapy among patients with muscle-invasive bladder cancer who undergo radical cystectomy

Smoking Associated With Worse Bladder Cancer Outcomes

Smokers had poorer response to cisplatin-based neoadjuvant chemotherapy, higher recurrence risk
Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces can detect bladder cancer with high diagnostic accuracy

Noninvasive Diagnostic Imaging Accurately IDs Bladder Cancer

Method evaluating cells collected from urine shows 94 percent diagnostic accuracy
Cancer treatment is associated with a clinically meaningful survival benefit in older

Treatment Tied to Survival Benefit in Complex Bladder Cancer

Medically complex patients with superficial disease have reduced deaths with treatment vs. observation
Compared with males

Gender Difference in Survival Seen After Radical Cystectomy

Females have worse disease-free, cancer-specific, overall survival versus males with bladder cancer
For patients with non-muscle invasive bladder cancer

PPD Skin Test Enhances Bacillus Calmette-Guérin Tx in Bladder CA

Enhanced therapeutic effect of bacillus Calmette-Guérin tx in non-muscle invasive bladder cancer
Immediate post-resection intravesical installation of gemcitabine is associated with reduced recurrence over four years for patients with suspected low-grade non-muscle-invasive urothelial cancer

Intravesical Gemcitabine Therapy Cuts Bladder Cancer Recurrence

Immediate post-resection gemcitabine reduces recurrence over 4 years in low-grade bladder cancer